Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer
Author:
Publisher
Elsevier BV
Subject
Genetics
Reference39 articles.
1. Drug resistance in non-small cell lung cancer: a potential for NOTCH targeting?;Sosa Iglesias;Front. Oncol.,2018
2. Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival;Araz;Clin. Respir. J.,2015
3. Treatment for non-small-cell lung cancer and circulating tumor cells;Mason;Lung Cancer Manag.,2017
4. Cisplatin: the first metal based anticancer drug;Ghosh;Bioorg. Chem.,2019
5. The landscape of circular RNA in cancer;Vo;Cell,2019
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circular RNAs in lung cancer: implications for preventing therapeutic resistance;eBioMedicine;2024-09
2. Emerging Roles of CircRNA-miRNA Networks in Cancer Development and Therapeutic Response;Non-coding RNA Research;2024-09
3. circPDK1 competitively binds miR-4731-5p to mediate GIGYF1 expression and increase paclitaxel sensitivity in non-small cell lung cancer;Discover Oncology;2024-05-11
4. Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities;Cancer Genomics - Proteomics;2023-11-30
5. circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway;Cell Death & Disease;2023-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3